Detalles de la búsqueda
1.
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
Clin Infect Dis
; 2024 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376212
2.
Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
HIV Med
; 25(1): 95-106, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670375
3.
Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir.
Ann Neurol
; 93(1): 88-102, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261315
4.
Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine.
J Hepatol
; 78(5): 937-946, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36669704
5.
Remdesivir for the Treatment of Covid-19 - Final Report.
N Engl J Med
; 383(19): 1813-1826, 2020 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445440
6.
Evaluating Primary Endpoints for COVID-19 Therapeutic Trials to Assess Recovery.
Am J Respir Crit Care Med
; 206(6): 730-739, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580040
7.
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.
Ann Intern Med
; 175(10): 1401-1410, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36037469
8.
No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adults.
HIV Med
; 23(3): 294-300, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34634168
9.
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3).
Clin Trials
; 19(1): 52-61, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34632800
10.
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial.
Lancet
; 395(10227): 888-898, 2020 03 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32085823
11.
Performance of human papillomavirus DNA detection in residual specimens taken for Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification testing in men who have sex with men.
Sex Transm Infect
; 97(7): 541-546, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328194
12.
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
N Engl J Med
; 377(3): 233-245, 2017 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28723333
13.
Corrigendum to "Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine" [J Hepatol (2023) 937-946].
J Hepatol
; 80(2): 379, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38182534
14.
Rash Reading: Rethinking Virginia Woolf's On Being Ill.
Lit Med
; 37(1): 26-66, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31402342
15.
Using Clinical Research Networks to Assess Severity of an Emerging Influenza Pandemic.
Clin Infect Dis
; 67(3): 341-349, 2018 07 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29746631
16.
Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
Clin Infect Dis
; 66(suppl_2): S132-S139, 2018 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29514234
17.
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
PLoS Med
; 15(12): e1002706, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30513108
18.
Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients.
Value Health
; 21(2): 210-218, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29477403
19.
Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization.
Clin Trials
; 14(3): 264-276, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28397569
20.
Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.
Clin Infect Dis
; 63(1): 122-32, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27048747